'They are suggesting 23% growth in the US this year. '
As GW decided not to share the current dose sales numbers, we are left with only our guesses. It would be nice to think 23% uptick the US was the go, but I suspect that are not hitting that yet. The trial data will be far too late in the year to have any impact.
Comfort in UBS commentary, page-8
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.17M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $122.1K | 909.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 698620 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 797342 | 14 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |